<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="level of antibody response after influenza vaccination Emerging Microbes &amp;amp;" exact="Infections" post="N. Lei et al. LeiNaab†LiYana†SunQiangacLuJianaZhouJianfangaLiZiaLiuLiqiaGuoJunfengaQinKunaWangHaibinbZhaoJianhongbLiChongbSunLinglibWangDayanaZhaoZhendongd†ShuYuelongac†CONTACT[a], National Institute for Viral"/>
 <result pre="&amp;amp; Infections N. Lei et al. LeiNaab†LiYana†SunQiangacLuJianaZhouJianfangaLiZiaLiuLiqiaGuoJunfengaQinKunaWangHaibinbZhaoJianhongbLiChongbSunLinglibWangDayanaZhaoZhendongd†ShuYuelongac†CONTACT[a], National Institute for" exact="Viral" post="Disease Control and Prevention, Chinese Center for Disease Prevention"/>
 <result pre="Infections N. Lei et al. LeiNaab†LiYana†SunQiangacLuJianaZhouJianfangaLiZiaLiuLiqiaGuoJunfengaQinKunaWangHaibinbZhaoJianhongbLiChongbSunLinglibWangDayanaZhaoZhendongd†ShuYuelongac†CONTACT[a], National Institute for Viral" exact="Disease" post="Control and Prevention, Chinese Center for Disease Prevention and"/>
 <result pre="Institute for Viral Disease Control and Prevention, Chinese Center for" exact="Disease" post="Prevention and ControlPeople’s Republic of China[b], Chaoyang District Center"/>
 <result pre="Prevention and ControlPeople’s Republic of China[b], Chaoyang District Center for" exact="Disease" post="Prevention and ControlPeople’s Republic of China[c], School of Public"/>
 <result pre="CollegePeople’s Republic of China CONTACT Yuelong Shu shuylong@mail.sysu.edu.cnNational Institute for" exact="Viral" post="Disease Control and Prevention, Chinese Center for Disease Prevention"/>
 <result pre="Republic of China CONTACT Yuelong Shu shuylong@mail.sysu.edu.cnNational Institute for Viral" exact="Disease" post="Control and Prevention, Chinese Center for Disease Prevention and"/>
 <result pre="Institute for Viral Disease Control and Prevention, Chinese Center for" exact="Disease" post="Prevention and Control, Beijing, 102206, People’s Republic of China"/>
 <result pre="we detected the haemagglutination inhibition (HI) of 171 healthy young" exact="adult" post="volunteers (IFITM3 rs12252-C/C, C/T, T/T carriers) and in an"/>
 <result pre="H3N2 and B viruses in IFITM3 rs12252-C/C genotype carriers was" exact="lower" post="compared with C/T and T/T donors. Significantly lower levels"/>
 <result pre="carriers was lower compared with C/T and T/T donors. Significantly" exact="lower" post="levels of specific antibodies to H1N1, H3N2 and B"/>
 <result pre="of specific antibodies to H1N1, H3N2 and B viruses and" exact="total" post="IgG were observed in Ifitm3-/- mice. Correspondingly, the numbers"/>
 <result pre="cells and T follicular helper cells in Ifitm3-/- mice were" exact="lower" post="compared with wild type mice. However, the number of"/>
 <result pre="7 after booster. The HI level of Ifitm3-/- mice remained" exact="lower" post="than WT mice after third vaccination. Moreover, the transcriptional"/>
 <result pre="vaccination. Moreover, the transcriptional network regulating GC B cell and" exact="plasma cell" post="differentiation was abnormal in Ifitm3-/- mice. Our results indicate"/>
 <result pre="a variety of factors that are able to fight Influenza" exact="virus infection" post="through various mechanisms. Interferon (IFN)-induced transmembrane protein (IFITM) 3"/>
 <result pre="variety of factors that are able to fight Influenza virus" exact="infection" post="through various mechanisms. Interferon (IFN)-induced transmembrane protein (IFITM) 3"/>
 <result pre="protein (IFITM) 3 is upregulated upon stimulation of cells by" exact="type I" post="and II IFNs [3]. IFITM3 is a 15-kDa membrane-associated"/>
 <result pre="protein that localizes to late endosomes and lysosomes and inhibits" exact="viral" post="entry into the host cell cytoplasm by impeding the"/>
 <result pre="RNA interference genomic screening for host factors involved in influenza" exact="virus infection" post="during the pandemic influenza H1N1/09 virus outbreak [6]. IFITM3"/>
 <result pre="interference genomic screening for host factors involved in influenza virus" exact="infection" post="during the pandemic influenza H1N1/09 virus outbreak [6]. IFITM3"/>
 <result pre="one of the most potent antiviral factors in restricting influenza" exact="virus infection," post="as IFITM3 knockout mice displayed enhanced morbidity and mortality"/>
 <result pre="displayed enhanced morbidity and mortality associated with pandemic influenza H1N1/09" exact="virus infection" post="[7]. Several distinct studies have revealed that IFITM3 plays"/>
 <result pre="enhanced morbidity and mortality associated with pandemic influenza H1N1/09 virus" exact="infection" post="[7]. Several distinct studies have revealed that IFITM3 plays"/>
 <result pre="after challenge with influenza virus, enabling the mice to withstand" exact="viral infection" post="during a secondary challenge and effecting quick protection at"/>
 <result pre="challenge with influenza virus, enabling the mice to withstand viral" exact="infection" post="during a secondary challenge and effecting quick protection at"/>
 <result pre="virus, enabling the mice to withstand viral infection during a" exact="secondary" post="challenge and effecting quick protection at the site of"/>
 <result pre="secondary challenge and effecting quick protection at the site of" exact="viral" post="entry [9]. Additionally, respiratory dendritic cells up-regulate the expression"/>
 <result pre="quick protection at the site of viral entry [9]. Additionally," exact="respiratory" post="dendritic cells up-regulate the expression of IFITM3 in response"/>
 <result pre="cells up-regulate the expression of IFITM3 in response to influenza" exact="virus infection" post="[10]. An important single nucleotide polymorphism (SNP) rs12252-C of"/>
 <result pre="up-regulate the expression of IFITM3 in response to influenza virus" exact="infection" post="[10]. An important single nucleotide polymorphism (SNP) rs12252-C of"/>
 <result pre="in adults during H1N1/09 virus infections, as well as following" exact="infection" post="with the novel H7N9 virus [11,12]. The underlying mechanisms"/>
 <result pre="[15]. Vaccination is the most effective method to prevent influenza" exact="virus infection." post="Growing evidence suggests that host factors including host genetics,"/>
 <result pre="TIV immunization. In this study, we recruited 171 healthy young" exact="adult" post="volunteers who received TIV and observed the seroconversion rates"/>
 <result pre="H1N1, H3N2 and B viruses. SCRs were found to be" exact="lower" post="in donors with IFITM3 rs12252-C/C genotype compared with rs12252-C/T"/>
 <result pre="compared with rs12252-C/T or T/T genotype. We also found a" exact="lower" post="level antibody after TIV booster in Ifitm3-/- mice. Further"/>
 <result pre="mice. Further analysis of germinal centre (GC) B cell and" exact="plasma cell" post="indicated a similar reduction in Ifitm3-/- mice. These findings"/>
 <result pre="influenza vaccination. Materials and methods Study cohort and ethics A" exact="total" post="of 212 healthy young adult volunteers (age from 18"/>
 <result pre="Study cohort and ethics A total of 212 healthy young" exact="adult" post="volunteers (age from 18 to 59 years) from the"/>
 <result pre="by the Ethics Review Committee of the National Institute for" exact="Viral" post="Disease Control and Prevention (NIVDC, assurance number, 200916), and"/>
 <result pre="the Ethics Review Committee of the National Institute for Viral" exact="Disease" post="Control and Prevention (NIVDC, assurance number, 200916), and written"/>
 <result pre="a pathogen free animal facility at the Chinese Center for" exact="Disease" post="Control and Prevention. Seven to ten-week-old female wild type"/>
 <result pre="Chinese Center for Disease Control and Prevention. Seven to ten-week-old" exact="female" post="wild type (WT) and congenic Ifitm3-/- mice were immunized"/>
 <result pre="by the World Health Organization [19]. Enzyme-linked immunosorbent assay (ELISA)" exact="Total" post="IgG against H1N1, H3N2, and B/Victoria viruses were determined"/>
 <result pre="filtration plate (Millipore, MA) following the manufacturer’s instructions for the" exact="Mouse" post="IgG ELISpotBASIC kit (Mabtech, Sweden). The spots were read"/>
 <result pre="for SDS – PAGE followed by Western blotting. The following" exact="primary" post="polyclonal antibodies were used: rabbit anti-IFITM3 (Proteintech, Chicago), rabbit"/>
 <result pre="rabbit anti-mouse IgG-HRP (Santa Cruz Biotechology, Texas) were used as" exact="secondary" post="antibodies. ECL western blotting detection reagents (Solarbio, Beijing) were"/>
 <result pre="reagents (Solarbio, Beijing) were used for detection. Quantitative real-time PCR" exact="Total" post="mouse RNA was extracted and reverse transcribed to cDNA,"/>
 <result pre="prepared with GraphPad Prism v 5 (GraphPad Software, CA). Results" exact="Antibody" post="responses in adults after TIV immunization Two hundred and"/>
 <result pre="and B viruses in donors with IFITM3 rs12252-C/C genotype was" exact="lower" post="compared with donors carrying the T/T genotypes (Figure 1b)."/>
 <result pre="and B viruses in donors with IFITM3 rs12252-C/C genotype were" exact="lower" post="than donors with TT genotype after TIV immunization (Figure"/>
 <result pre="deletion mouse model for further investigation. IFITM3 deletion resulted in" exact="lower" post="antibody response after TIV immunization in mice To investigate"/>
 <result pre="blood before immunization and at days 0 (14 days after" exact="primary" post="immunization), 7, 14, 21 and 28 after booster immunization"/>
 <result pre="against H1N1, H3N2 and B/Victoria viruses in Ifitm3-/- mice were" exact="lower" post="than those in WT mice after booster vaccination (Figure"/>
 <result pre="against A/Michigan/45/2015 (H1N1), A/Hong Kong/4801/2015 (H3N2) and B/Brisbane/60/2008 (B/Victoria). (c)" exact="Total" post="IgG was investigated by ELISA with split H1N1, H3N2"/>
 <result pre="immunization compared with WT mice (Figure 2c). The levels of" exact="total" post="IgG peaked at day 14 in Ifitm3-/- mice, which"/>
 <result pre="the peak observed in WT mice, for which the peak" exact="total" post="IgG was at day 7. These results showed that"/>
 <result pre="differences are marked by * P &amp;lt; 0.05, ** P &amp;lt; 0.01, *** P &amp;lt; 0.001." exact="Dysfunction" post="of GC-to-plasma/memory transition was detected in Ifitm3-/- mice In"/>
 <result pre="B cells appear within 1 week and peak in the" exact="peripheral" post="blood around day 7 post-influenza immunization, which indicates that"/>
 <result pre="number of memory cells in spleens of Ifitm3-/- mice increases." exact="Follicular" post="helper T (TFH) cells reduced in Ifitm3-/- mice Inside"/>
 <result pre="** P &amp;lt; 0.01, *** P &amp;lt; 0.001. Ab levels in Ifitm3-/- mice remained" exact="lower" post="than those in WT mice after third TIV immunization"/>
 <result pre="21, 28 and 32. The HI and IgG levels were" exact="lower" post="in Ifitm3-/- mice at day 7 after boosting compared"/>
 <result pre="this, the HI and IgG level of Ifitm3-/- mice remained" exact="lower" post="than WT mice and there was no significant difference"/>
 <result pre="each HA). The twice immunization was at day 14 after" exact="primary" post="immunization, then the third immunization was at day 7"/>
 <result pre="against A/Michigan/45/2015 (H1N1), A/Hong Kong/4801/2015 (H3N2) and B/Brisbane/60/2008 (B/Victoria). (c)" exact="Total" post="IgG was investigated by ELISA with split H1N1, H3N2"/>
 <result pre="are committed to become TFH cells, which upregulate B cell" exact="lymphoma" post="6 (BCL6). BCL6 is a master regulator which progresses"/>
 <result pre="Discussion IFITM3 is an important antiviral factor in restricting influenza" exact="virus infection." post="The SNP rs12252-C allele of IFITM3 had been linked"/>
 <result pre="immunization. Our results showed that IFITM3 rs12252-C/C carriers exhibited a" exact="lower" post="level of antibody response to H1N1, H3N2 and B"/>
 <result pre="to pdm09H1N1 in volunteers with the rs12252-C/C genotype was much" exact="lower" post="than the change in rs12252-T/T genotypes on both days"/>
 <result pre="are the principal sites of affinity maturation of antigen-specific immunoglobulin," exact="transient" post="structures induced by T cell-dependent (TD) antigens [39]. TFH"/>
 <result pre="for which GC B cells compete to survive and undergo" exact="clonal" post="expansion [40]. Proliferating GC B cells differentiate into plasma"/>
 <result pre="ASCs were decreased in Ifitm3-/- mice, which may explain the" exact="lower" post="level of antibody response. We also found a decreased"/>
 <result pre="dynamics of splenic GC B cells, high-affinity antibody development and" exact="plasma cell" post="differentiation, such as BCL6 or Blimp1, which are considered"/>
 <result pre="which are considered to be master regulators for GC or" exact="plasma cell" post="development, were abnormal in Ifitm3-/- mice [32]. BCL6 inhibits"/>
 <result pre="encode BCL6 [34]. So, BCL6 is a known inhibitor of" exact="plasma cell" post="differentiation and thus promotes memory B cell differentiation [41,42]."/>
 <result pre="diminishes the antibody response and IFITM3 SNP rs12252-C/C carriers show" exact="lower" post="antibody levels after TIV immunization. The frequency of the"/>
 <result pre="was reported by the author(s). References References 1collab: Centers for" exact="Disease" post="C, PreventionEstimates of deaths associated with seasonal influenza —"/>
 <result pre="Biol Chem. 2012;287(23):19631–19641.22511783 5LiK, MarkosyanRM, ZhengYM, et al.IFITM proteins restrict" exact="viral" post="membrane hemifusion. PLoS Pathog. 2013;9(1):e1003124.23358889 6BrassAL, HuangIC, BenitaY, et"/>
 <result pre="of IFITM3 following T cell activation protects cells from influenza" exact="virus infection." post="PLoS One. 2019;14(1):e0210132.30650117 9WakimLM, GuptaN, MinternJD, et al.Enhanced survival"/>
 <result pre="al.Enhanced survival of lung tissue-resident memory CD8(+) T cells during" exact="infection" post="with influenza virus due to selective expression of IFITM3."/>
 <result pre="SmithJM, YuanH, et al.Respiratory DC Use IFITM3 to avoid direct" exact="viral infection" post="and safeguard virus-specific CD8+ T cell priming. PLoS One."/>
 <result pre="YuanH, et al.Respiratory DC Use IFITM3 to avoid direct viral" exact="infection" post="and safeguard virus-specific CD8+ T cell priming. PLoS One."/>
 <result pre="al.ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent" exact="plasma cell" post="differentiation. Sci Signal. 2011;4(169):ra25.21505187 35BaranovichT, VongphrachanhP, KetmayoonP, et al.Antiviral"/>
 <result pre="2017;23(4):686–690.28322707 36ToddDJ, McHeyzer-WilliamsLJ, KowalC, et al.XBP1 governs late events in" exact="plasma cell" post="differentiation and is not required for antigen-specific memory B"/>
</results>
